Poison control calls spike for unapproved drug that produces opioid-like highs
(By Megan Thielking for ST A T) Calls to U.S. poison control centers about an unapproved antidepressant that has opioid-like
Read More
Part D/Prescription Drugs
Senate hosts 3rd hearing on healthcare costs: 5 takeaways
(By Emily Rappleye for Becker’s Hospital Review ) A Senate panel tackled administrative spending in healthcare during a hearing July
Read MoreHow Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers
(By Fred Schulte for Kaiser Health News) As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers
Read MoreMedicare Drug plan benchmark price falls
According to CMS officials, vigorous bidding helped cut the drug plan national average monthly bid amount for 2019 to $51.28,
Read MorePfizer CEO predicts that controversial rebates are ‘going away’
(By Ed Silverman for ST A T) In his first public remarks since rescinding price hikes, Pfizer chief executive officer
Read MorePatients With Chronic Pain Feel Caught In An Opioid-Prescribing Debate
(By Will Stone for Kaiser Health News) It started with a rolled ankle during a routine Army training exercise. Shannon
Read MoreTo Tame Prescription Prices, HHS Dips A Toe Into Drug Importation Stream
(By Rachel Bluth for Kaiser Health News) It came as something of a surprise when Health and Human Services Secretary
Read MoreAlzheimer’s study sparks a new round of debate over the amyloid hypothesis
(By Damian Garde for ST A T) In the long-running debate over just what causes Alzheimer’s disease, one side looks
Read MoreDrug Trade Group Quietly Spends ‘Dark Money’ To Sway Policy And Voters
(By Jay Hancock for Kaiser Health News) In 2010, before the Affordable Care Act was passed by Congress, the pharmaceutical
Read MoreThe Medicare Part D program could have saved $3 billion in 2016
According to new data from Health and Human Services (HHS), using generic drugs instead of their brand-name equivalents could have
Read More